(Q40776007)

23 September 2017

Antibodies to PAI-1 alter the invasive and migratory properties of human tumour cells in vitro (English)

1 reference

23 September 2017

3

1 reference

23 September 2017

Brooks TD

1

1 reference

23 September 2017

Slomp J

2

1 reference

23 September 2017

De Bart AC

4

1 reference

23 September 2017

Spencer MT

5

1 reference

23 September 2017

Verheijen JH

6

1 reference

23 September 2017

Charlton PA

7

1 reference

23 September 2017

1 January 2000

1 reference

Clinical & Experimental Metastasis

23 September 2017

1 reference

23 September 2017

18

1 reference

23 September 2017

445-453

1 reference

23 September 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1011882421528

23 September 2017

0 references

cites work

Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin

1 reference

12 December 2020

The plasminogen activation system in tumor growth, invasion, and metastasis

1 reference

12 December 2020

Lack of plasminogen activator inhibitor-1 effect in a transgenic mouse model of metastatic melanoma

1 reference

12 December 2020

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

12 December 2020

Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation

1 reference

12 December 2020

Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model

1 reference

12 December 2020

Role of serum vitronectin and fibronectin in adhesion of fibroblasts following seeding onto tissue culture polystyrene

1 reference

12 December 2020

A study of proteases and protease-inhibitor complexes in biological fluids

1 reference

12 December 2020

Mapping of binding sites for heparin, plasminogen activator inhibitor-1, and plasminogen to vitronectin's heparin-binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formation

1 reference

12 December 2020

Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells

1 reference

12 December 2020

Hepatocyte adhesion on plastic. Different mechanisms for serum- and fibronectin-mediated adhesion

1 reference

12 December 2020

Adhesion and growth of cultured human endothelial cells on perfluorosulphonate: role of vitronectin and fibronectin in cell attachment

1 reference

12 December 2020

Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator

1 reference

12 December 2020

alphaV Integrins on HT-29 colon carcinoma cells: adhesion to fibronectin is mediated solely by small amounts of alphaVbeta6, and alphaVbeta5 is codistributed with actin fibers

1 reference

12 December 2020

In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis

1 reference

12 December 2020

Kinetic analysis of integrin-dependent cell adhesion on vitronectin--the inhibitory potential of plasminogen activator inhibitor-1 and RGD peptides.

1 reference

12 December 2020

Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness

1 reference

12 December 2020

The antibody to plasminogen activator inhibitor-1 suppresses pulmonary metastases of human fibrosarcoma in athymic mice.

1 reference

12 December 2020

The PAI-1/vitronectin interaction: two cats in a bag?

1 reference

12 December 2020

Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2

1 reference

12 December 2020

A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma

1 reference

12 December 2020

Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation

1 reference

12 December 2020

Plasminogen activator inhibitor-1 and prognosis in primary breast cancer

1 reference

12 December 2020

Modified proenzymes as artificial substrates for proteolytic enzymes: colorimetric assay of bacterial collagenase and matrix metalloproteinase activity using modified pro-urokinase

1 reference

12 December 2020

Involvement of finger domain and kringle 2 domain of tissue-type plasminogen activator in fibrin binding and stimulation of activity by fibrin

1 reference

12 December 2020

The urokinase receptor is a major vitronectin-binding protein on endothelial cells

1 reference

12 December 2020

A rapid method for site-specific mutagenesis and directional subcloning by using the polymerase chain reaction to generate recombinant circles.

1 reference

12 December 2020

Introduction of lysine and clot binding properties in the kringle one domain of tissue-type plasminogen activator

1 reference

12 December 2020

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.

1 reference

12 December 2020

The urokinase-type plasminogen activator system in cancer metastasis: a review

1 reference

12 December 2020

uPA, uPAR, PAI-1: key intersection of proteolytic, adhesive and chemotactic highways?

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1011882421528

1 reference

Dimensions Publication ID

23 September 2017

0 references

1 reference